Bial
Founded in 1924, BIALÕs mission is to discover, develop and provide new therapeutic solutions within the area of Health. Today, BIAL is an innovative international pharmaceutical company with products available in more than 55 countries. The company is committed to making a contribution to improve human health and quality of life for people from all over the world. Our strategic areas are Innovation, Internationalisation and Quality. Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), BIAL has established an ambitious R&D programme. Key focus areas for the Group are the neurosciences and cardiovascular. BIAL has launched eslicarbazepine acetate, an epilepsy drug, already available in the US and in several European countries. BIAL has also developed a ParkinsonÕs disease compound, opicapone, also commercialized in Europe. The company expects to introduce new medicines to the market over the next few years, strengthening its international presence. The company headquarters are located in Portugal. BIAL has also facilities in Spain, Germany, United Kingdom, Italy, Switzerland, Mozambique, Angola, Panama and Ivory Coast. BIAL Group is a member of the ÒEuropean Federation of Pharmaceutical Industries and AssociationsÓ (EFPIA). BIAL Group has also been distinguished by its support to several medical and scientific activities, namely through BIAL Foundation, having as outstanding events the BIAL Award and Scientific Research Grants, well recognized worldwide. For more information, please visit: www.bial.com For issues of safety or others related to product quality, please contact: pharmacovigilance@bial.com
Pharmaceuticals
About

Founded in 1924, BIALÕs mission is to discover, develop and provide new therapeutic solutions within the area of Health. Today, BIAL is an innovative international pharmaceutical company with products available in more than 55 countries. The company is committed to making a contribution to improve human health and quality of life for people from all over the world. Our strategic areas are Innovation, Internationalisation and Quality.

Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), BIAL has established an ambitious R&D programme. Key focus areas for the Group are the neurosciences and cardiovascular.

BIAL has launched eslicarbazepine acetate, an epilepsy drug, already available in the US and in several European countries. BIAL has also developed a ParkinsonÕs disease compound, opicapone, also commercialized in Europe. The company expects to introduce new medicines to the market over the next few years, strengthening its international presence.

The company headquarters are located in Portugal. BIAL has also facilities in Spain, Germany, United Kingdom, Italy, Switzerland, Mozambique, Angola, Panama and Ivory Coast.

BIAL Group is a member of the ÒEuropean Federation of Pharmaceutical Industries and AssociationsÓ (EFPIA).

BIAL Group has also been distinguished by its support to several medical and scientific activities, namely through BIAL Foundation, having as outstanding events the BIAL Award and Scientific Research Grants, well recognized worldwide.

For more information, please visit: www.bial.com

For issues of safety or others related to product quality, please contact: pharmacovigilance@bial.com

Site Traffic
  • 1373114 Global Rank
  • 14365
    Portugal
  • 159 K Estimated Visits
Traffic Sources
  • Search
    82.43%
  • Direct
    16.12%
  • Social
    1.21%
  • Referrals
    0.24%
  • Display
    0.00%
  • Mail
    0.00%
Powered by
Alexa Traffic Data
Global Rank 312,789
6,945,259
Portugal Rank 1,919
4,925
Portugal Page Views 100.0%
3.1%
Top Countries
Top Search Keywords
  • Opportunities
  • Partners Programs
  • Amazon Associates Program
Mobile App Data
MixRank is the most comprehensive database of mobile apps, developers, SDKs, technologies, services, and integrations. Learn more.
  • 0 SDKs
  • App Url: https://itunes.apple.com/app/bial/id1071767033
  • App Support: https://www.bial.com/en/bial_foundation.11/11th_symposium.219/11th_symposium_behind_and_beyond_the_brain.a533.html
  • Genre: Productivity
  • Bundle ID: com.braininnovation.BIAL11
  • App Size: 44.6 M
  • Version: 1.1
  • Release Date: March 16th, 2016
  • Update Date: March 25th, 2016

Description:

This app contains the program for the 11th BIAL Symposium “Behind and Beyond the Brain”. The topic of the meeting is: PLACEBO EFFECTS, HEALING AND MEDITATION.

You can swipe right/left through the main pages, i.e. when the Home icon in the bar at the bottom of the app is selected. Each page corresponds to one day of the conference. Tap on a program item within a day to get details about a lecture and its presenter as well as details about workshops and posters from BIAL fellows.

For general information about the meeting, tap the middle (Info) button in the tab bar at the bottom. You can click on links to open pages on the BIAL website for last-minute updates of the conference program. To go back, use the middle button that will change to a Back icon when browsing to a web page.

A PDF version of the program as well as the first announcement of the conference can be found by clicking the button on the right side of the bar at the bottom of the app.

Ad Intelligence
  • Standard
    0%
Ads Seen Recently
0
Longest Running Ad
Bial
Device
Desktop
Dimensions
other
They have advertising & marketing contacts listed on Kochava. Bial works with Advertising technology companies such as DoubleClick.Net.